Amgen to Invest $650M in U.S. Production Expansion as Trump Hikes Tariffs

Dow Jones
2025/09/26
 

By Nicholas G. Miller

 

Amgen said it would invest $650 million in expanding its U.S manufacturing network, a day after President Trump said he would impose a 100% tariff on pharmaceuticals produced by companies that are not building plants in the U.S.

Amgen said the investment would support production at the company's manufacturing facility in Juncos, Puerto Rico. The company said the expansion builds on recent investments in the U.S., including manufacturing expansions of $900 million in Ohio and $1 billion in North Carolina.

On Thursday, President Trump said he would impose a new 100% tariff on pharmaceuticals but that companies building out manufacturing in the U.S. would be exempt.

"Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America," Trump posted on his social media site, Truth Social, on Thursday.

 

Write to Nicholas G. Miller at nicholas.miller@wsj.com.

 

(END) Dow Jones Newswires

September 26, 2025 09:18 ET (13:18 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10